Search - tctmd.com

Displaying 301 - 320 of 343

Sort: Relevancy | Date

Presentation TCT 2013

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Presenter: Pim Tonino

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Presenter: Kevin Beatt

October 30, 2013

Presentation TCT 2013

Case #2: Management of Acute MI with Cardiogenic Shock and Multivessel Coronary Disease

Presenter: Eric Van Belle

October 29, 2013

Presentation TCT 2013

Synthesis of the Current US and EU Guidelines for Management of Multivessel and Left Main Disease (Similarities and Differences)

Presenter: Eric Bates

October 29, 2013

Presentation TCT 2013

PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making

Presenter: Marie-Claude Morice

October 29, 2013

Presentation TCT 2013

Case Presentations: The Issue: Introducing Two Cases That Might Invoke Different Revascularization Approaches (Multivessel and Left Main Disease)

Presenter: Vasim Farooq

October 29, 2013

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Presenter: Gregory Dehmer

October 29, 2013

Presentation TCT 2013

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

Presenter: Vasim Farooq

October 27, 2013

Presentation SOLACI 2013

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: The Surgeon Perspective

Presenter: Fabio B. Jatene

July 26, 2013

Presentation

Long-term Analysis of LVEF in Patients with Stable Multivessel Coronary Disease Undergoing Medicine, Angioplasty, or Surgery

Presenter: Cibele Larrosa Garzillo

July 09, 2013

Presentation

One-Stop Hybrid Coronary Revascularization (HCR) vs. CABG and PCI for Multivessel Disease

Presenter: L. Shen

April 23, 2013

Presentation Fellows 2013

Revascularization in Multivessel Disease: PCI vs CABG for Nondiabetic and Diabetic Patients

Presenter: William Fearon

April 15, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI and CABG for Multivessel Disease

Presenter: Ajay J. Kirtane

March 07, 2013

Presentation CTO 2013

Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging

Presenter: Antonio Colombo

February 22, 2013

Presentation TCT 2013

Impact of Multivessel Coronary Artery Disease With or Without a Concurrent Chronic Total Occlusion on Survival in Patients Treated With Rescue Angioplasty

Presenter: Francesco De Felice, Rosario Fiorilli, Antonio Parma, Carmine Musto, Marco Nazzaro, Pierpaolo Confessore, Massimiliano Scappaticci, Elena Guerra, Roberto Violini

January 31, 2013

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Long-term Outcomes of Complete versus Incomplete Revascularization After Drug-Eluting Stent Implantation in Patients with Multivessel Coronary Disease

Presenter: Zhan Gao, Bo Xu, Yuejin Yang, Shubin Qiao, Hongbing Yan, Yongjian Wu, Xuewen Qin, Min Yao, Haibo Liu, Jinqing Yuan, Jue Chen, Jun Dai, Tao Chen, Siyong Teng, JiLin CHEN, Run-Lin Gao

January 31, 2013

Presentation TCT 2013

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Presenter: Bo Xu, Yuejin Yang, Yaling Han, Bao Li, Qiang Liu, Guoying Zhu, Junyu Cui, Lang Li, Shuzheng Lu

January 31, 2013

Presentation TCT 2013

Chronic Total Occlusion Lesion Revascularization Alone versus Complete Revascularization in Chronic Total Occlusion Patients with Multivessel Disease

Presenter: Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 31, 2013

Advertisement

FFR in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Case #2: Management of Acute MI with Cardiogenic Shock and Multivessel Coronary Disease

Synthesis of the Current US and EU Guidelines for Management of Multivessel and Left Main Disease (Similarities and Differences)

PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making

Case Presentations: The Issue: Introducing Two Cases That Might Invoke Different Revascularization Approaches (Multivessel and Left Main Disease)

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: The Surgeon Perspective

Long-term Analysis of LVEF in Patients with Stable Multivessel Coronary Disease Undergoing Medicine, Angioplasty, or Surgery

One-Stop Hybrid Coronary Revascularization (HCR) vs. CABG and PCI for Multivessel Disease

Revascularization in Multivessel Disease: PCI vs CABG for Nondiabetic and Diabetic Patients

Perspectives on PCI and CABG for Multivessel Disease

Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging

Impact of Multivessel Coronary Artery Disease With or Without a Concurrent Chronic Total Occlusion on Survival in Patients Treated With Rescue Angioplasty

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Long-term Outcomes of Complete versus Incomplete Revascularization After Drug-Eluting Stent Implantation in Patients with Multivessel Coronary Disease

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Chronic Total Occlusion Lesion Revascularization Alone versus Complete Revascularization in Chronic Total Occlusion Patients with Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content